409 related articles for article (PubMed ID: 30115078)
1. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
[TBL] [Abstract][Full Text] [Related]
2. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
[TBL] [Abstract][Full Text] [Related]
3. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
Cheng T; Xu Y
Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
[TBL] [Abstract][Full Text] [Related]
4. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
[TBL] [Abstract][Full Text] [Related]
5. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
Duan M; Hu F; Li D; Wu S; Peng N
Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.
Wang CI; Chien KY; Wang CL; Liu HP; Cheng CC; Chang YS; Yu JS; Yu CJ
Mol Cell Proteomics; 2012 Nov; 11(11):1105-22. PubMed ID: 22843992
[TBL] [Abstract][Full Text] [Related]
7. MiR-1297 negatively regulates metabolic reprogramming in glioblastoma via repressing KPNA2.
Li H; Yuan H
Hum Cell; 2020 Jul; 33(3):619-629. PubMed ID: 32124270
[TBL] [Abstract][Full Text] [Related]
8. PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop.
Luan W; Wang Y; Chen X; Shi Y; Wang J; Zhang J; Qian J; Li R; Tao T; Wei W; Hu Q; Liu N; You Y
Oncotarget; 2015 May; 6(15):13006-18. PubMed ID: 25948776
[TBL] [Abstract][Full Text] [Related]
9. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
10. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
Wang G; Wang J; Zhao H; Wang J; Tony To SS
Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
[TBL] [Abstract][Full Text] [Related]
11. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.
Duan K; Liu ZJ; Hu SQ; Huo HY; Xu ZR; Ruan JF; Sun Y; Dai LP; Yan CB; Xiong W; Cui QH; Yu HJ; Yu M; Qin Y
Biochem Biophys Res Commun; 2018 Sep; 503(2):888-894. PubMed ID: 29928884
[TBL] [Abstract][Full Text] [Related]
12. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc.
Lee DH; Kim GW; Yoo J; Lee SW; Jeon YH; Kim SY; Kang HG; Kim DH; Chun KH; Choi J; Kwon SH
Cell Death Dis; 2021 Jan; 12(1):89. PubMed ID: 33462212
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Imaging Detects Low Levels of Glycolytic Activity That Vary with Levels of c-Myc Expression in Patient-Derived Xenograft Models of Glioblastoma.
Mair R; Wright AJ; Ros S; Hu DE; Booth T; Kreis F; Rao J; Watts C; Brindle KM
Cancer Res; 2018 Sep; 78(18):5408-5418. PubMed ID: 30054337
[No Abstract] [Full Text] [Related]
16. NKAP alters tumor immune microenvironment and promotes glioma growth via Notch1 signaling.
Gu G; Gao T; Zhang L; Chen X; Pang Q; Wang Y; Wang D; Li J; Liu Q
J Exp Clin Cancer Res; 2019 Jul; 38(1):291. PubMed ID: 31277684
[TBL] [Abstract][Full Text] [Related]
17. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas.
Miranda-Gonçalves V; Granja S; Martinho O; Honavar M; Pojo M; Costa BM; Pires MM; Pinheiro C; Cordeiro M; Bebiano G; Costa P; Reis RM; Baltazar F
Oncotarget; 2016 Jul; 7(29):46335-46353. PubMed ID: 27331625
[TBL] [Abstract][Full Text] [Related]
19. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
[TBL] [Abstract][Full Text] [Related]
20. miR-135a-5p Functions as a Glioma Proliferation Suppressor by Targeting Tumor Necrosis Factor Receptor-Associated Factor 5 and Predicts Patients' Prognosis.
Luo W; Sun C; Zhou J; Wang Q; Yu L; Bian XW; Zhou X; Hua D; Wang R; Rao C; Jiang Z; Shi C; Yu S
Am J Pathol; 2019 Jan; 189(1):162-176. PubMed ID: 30312580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
